Ramius Advisors’s Exact Sciences EXAS Stock Holding History

Ramius Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-41,258	Closed	-$3.73M	–	69
2019 Q3	$3.73M	Buy	+41,258	New	+$4.7M	0.88%	17

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Ramius Advisors's EXAS Position: Q4 2019 in Review

Ramius Advisors sold out of Exact Sciences (EXAS) in Q4 2019, closing a stake of 41,258 shares — an estimated $3.73M sold.

Ramius Advisors first reported a position in EXAS in Q3 2019 and held it in 1 quarter. The position peaked at $3.73M in Q3 2019. 526 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

Ramius Advisors reported no remaining Exact Sciences position as of Q4 2019 after selling out during the quarter.
Ramius Advisors sold 41,258 Exact Sciences shares in Q4 2019, an estimated $3.73M.
Ramius Advisors first reported a position in Exact Sciences in Q3 2019 and held it in 1 quarter.
Ramius Advisors's Exact Sciences position peaked at $3.73M in Q3 2019.
526 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Ramius Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.